Connect with us

Newsletters

The Capitalist Newsletter – December 21, 2016

Published

on

ROGUE ONE BLASTS DISNEY INTO NEW TERRITORY; BECOMES FIRST STUDIO TO GROSS $7 BILLION


Walt Disney studios has gone from Mickey Mouse to Darth Vader, and boy is it paying off. With Rogue One: A Star Wars Story having a worldwide opening weekend coup of $290 million, Disney has become the first movie studio in history to gross $7 billion globally at the box office. Where does the studio go from here? And just how high is the roof for The Walt Disney Company?

Read The Capitalist’s Take Here

Read More at USA Today

Read More at Fortune


FRED’S AGREES TO ACQUIRE 865 RITE AID STORES

In a bid to bolster its chances to buy Rite Aid, Walgreens Boots Alliance and Rite Aid said Tuesday that they plan to sell hundreds of Rite Aid locations to Fred's Inc.for $950 million.If the sale of the 865 stores gets the green light from regulators, Fred's would instantly become one of the biggest pharmacy chains in the U.S., and Walgreens' year-long quest to merge with its drug store rival would move closer to its goal of the deal closing at the start of next year.

Read More at USA Today Here

Read More at MarketWatch Here

Read More at CNBC Here


MARK ZUCKERBERG BUILDS SOFTWARE BUTLER – JARVIS FOR HIS HOME

Mark Zuckerberg's artificial intelligence-imbued software “butler” — named Jarvis — is now in service, and even plays with his family, the Facebook chief said Monday. Zuckerberg took on the personal project this year, devoting about 100 hours to making a system inspired by the “Iron Man” film character Jarvis as a virtual assistant to help manage his household..

Read More at Yahoo Here

Read More at TIME Here

Read More at Economic Times Here


Closing Bell

– Tuesday, December 20th

Dow Flirts with 20k as Financials Lead Markets Higher

Big Insider Trades

– Genesee & Wyoming, Inc. (GWR) Director Mortimer Fuller Sells $2m

-Infinity Pharmaceuticals, Inc. (INFI) Execs Buy $1..3m

Winners & Losers

– Conatus Pharmaceuticals, Inc. (CNAT) Skyrockets UP (141.33%) After Completing Licensing Deal with Novartis on Liver Drug

– Sucampo Pharmaceuticals, Inc. (SCMP) Falls DOWN (20.51%) After Company Announces Intention to Sell $259 Million in Debt

Most Talked About

Fred’s, Inc. (FRED) a Slight Majority Strong Buy After Spiking UP (81.08%) Following its Agreement to Purchase 865 Rite Aid Stores

The TIP Sheets

– Tuesday, December 20th

– Fred’s, Inc. (FRED) Jumps UP (81.08%) and Rite Aid Corporation (RAD) Ticks UP (5.39%) After Announcing Fred’s Will Purchase 865 Rite Aid Stores. Expect Shares of Both Companies to Continue UP

Unusual Volume

– ACADIA Pharmaceuticals, Inc. (ACAD) Jumps UP (12.35%) on 18.5m Shares Traded After Reporting the Company Met Primary Endpoints in a Critical Phase 2 Drug Trial to Treat Alzheimer’s Psychosis. The FDA has Not Yet Approved ANY Drug to Treat Alzheimer’s Psychosis, so if This Passes, Expect Shares to Rocket UP

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Continue Reading

Copyright © 2023 The Capitalist. his copyrighted material may not be republished without express permission. The information presented here is for general educational purposes only. MATERIAL CONNECTION DISCLOSURE: You should assume that this website has an affiliate relationship and/or another material connection to the persons or businesses mentioned in or linked to from this page and may receive commissions from purchases you make on subsequent web sites. You should not rely solely on information contained in this email to evaluate the product or service being endorsed. Always exercise due diligence before purchasing any product or service. This website contains advertisements.

wpChatIcon

Is THE newsletter for…

INVESTORS TRADERS OWNERS

Stay up-to-date with the latest kick-ass interviews, podcasts, and more as we cover a wide range of topics, in the world of finance and technology. Don't miss out on our exclusive content featuring expert opinions and market insights delivered to your inbox 100% FREE!